Epigenetic clocks and appeared to capture mostly non-overlapping aging signals in pediatric-onset multiple sclerosis.
Evidence
This cross-sectional case-control study analyzed whole-blood DNAm clocks and telomere T/S ratios in 270 participants, including 125 pediatric-onset MS cases and 145 controls.
Caveat
The analysis was cross-sectional, and the only hinted telomere-PhenoAge association was modest in controls and did not reach conventional significance.
Simplified
BACKGROUND: Age is the strongest factor determining disease expression in multiple sclerosis (MS). We previously demonstrated biological age acceleration in pediatric-onset MS (POMS) compared to controls with both epigenetic clocks (DNAm) and (TL). It is unknown whether these markers report overlapping or distinct aging-related processes.
OBJECTIVES: To determine the correlation between DNAm and TL aging markers.
METHODS: We conducted a cross-sectional case-control study within the US Network of Pediatric MS Centers. We calculated age acceleration residuals for the Horvath, Hannum, PhenoAge, and GrimAge epigenetic clocks and measured TL from whole blood samples to estimate telomere to somatic DNA ratios (T/S ratio). We employed multivariable analysis of covariance to assess the correlation between DNAm estimates and TL.
RESULTS: We analyzed biological ages in 270 participants (125 POMS, mean 15.7 years; 145 controls, mean 15.3 years). There were moderate correlations among the different DNAm clocks, but no correlations between DNAm clocks and TL in pooled analyses. In a stratified analysis, only the control group showed a modest correlation between TL and PhenoAge clock ( = 0.2, = 0.06). r p
CONCLUSIONS: DNAm did not correlate with TL in this sample of POMS and controls, suggesting that these biomarkers may capture complementary and non-overlapping elements of aging-related biology.
Full Text
We can’t show the full text here under this license.
